David Kegyes

Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?

H. Einsele, C. Tomuleasa, Diana Gulei, 2022, Journal of Hematology & Oncology.

Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemia.

C. Tomuleasa, D. Hoelzer, G. Ghiaur, 2023, Blood reviews.

Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma.

A. Ciechanover, H. Einsele, A. Buzoianu, 2023, Blood reviews.

COVID-19 Impact on Chronic Myeloid Leukemia Patients

C. Tomuleasa, D. Dima, A. Trifa, 2022, Journal of personalized medicine.

Immune Therapies of B-cell Acute Lymphoblastic Leukaemia in Children and Adults.

C. Tomuleasa, David Kegyes, Anamaria Bancos, 2024, Critical reviews in oncology/hematology.

A mathematical model of clonal hematopoiesis explaining phase transitions in myeloid leukemia

C. Tomuleasa, L. Parajdi, David Kegyes, 2024, 2401.05316.

Therapeutic advances of targeting receptor tyrosine kinases in cancer

C. Tomuleasa, Anca Onaciu, A. Țigu, 2024, Signal transduction and targeted therapy.

Looking ahead to targeting macrophages by CAR T- or NK-cells in blood cancers.

C. Tomuleasa, A. Țigu, David Kegyes, 2024, Expert opinion on therapeutic targets.